KRAS AND BRAF MUTATIONAL ANALYSES IN A PHASE II TRIAL OF FIRST-LINE FOLFOXIRI PLUS BEVACIZUMAB (BV) IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS)L. Salvatore,F. Loupakis,C. Cremolini,C. Lupi,G. Masi,E. Sensi,I Stasi,L. Fornaro,E. Vasile,M. Schirripa, K. Truscelli,R. Giannini,G. G. Baldi,A. Altavilla, A. Ciarlo,C. Granetto,E. Fea,G. Fontanini,F. Basolo,A. FalconeEJC SUPPLEMENTS（2009）引用 3|浏览79暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
